TearLab Corp (NASDAQ: TEAR) is a company that is on the verge of tears, literally. Its star product tests tears for the diagnosis of dry eye disease. The sales of that product have shot up so much that the company had to expand its manufacturing capacity from 200 units a month to 240. Sales are expected to double in 2013 over their 2012 levels and double again in 2014. Moreover more »
Generally speaking, activist hedge funds usually receive wider media coverage than their passive peers. One of the activist hedge funds we track is Richard Breeden's Breeden Capital Management. Unlike the Carl Icahns or David Einhorns of the world, Breeden does not get much press. Still, he’s an investor with an activist history worth watching. His hedge fund has recently filed its first quarter 13F form with the SEC more »
Sumitomo is one of many copper miners expanding capacity as its margins deteriorate. If copper prices decline based on lower demand from ebbing construction or price competition, lower margins become dangerous.
Price competition is a big problem facing commodity producers. Investors should demand cheap valuations for commodity stocks to compensate them for the risks associated with producing a non-differentiated product. Do copper stocks offer sufficiently low valuations?
Sumitomo's Expansion more »
Do you ever get tired of the same stocks being fed to you on a daily basis by the media? Like the stock market only consists of Microsoft, Amazon, Google, and Apple, right? For those of you looking for investments not so mainstream but that have a good track record, here are 5 stocks worth a look.